Special AT-rich sequence binding protein 1 regulates the multidrug resistance and invasion of human gastric cancer cells

Oncology Letters

Volumn 4, Issue 1, 2012, Pages 156-162

  Sun, Fuqiang ^a   Lu, Xiaoming ^a   Li, Hang ^a   Peng, Zhao ^a   Wu, Ke ^a   Wang, Guobin ^a   Tong, Qiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Chemotherapy; Gastric cancer; Invasion; Multidrug resistance; Special AT rich sequence binding protein 1

Indexed keywords

BINDING PROTEIN; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1; UNCLASSIFIED DRUG; VINCRISTINE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL INVASION; CONTROLLED STUDY; DRUG SENSITIVITY; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 84861319441     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.681     Document Type: Article

References (27)

1. Han HJ, Russo J, Kohwi Y and Kohwi-Shigematsu T: SATB1 reprogrammes gene expression to promote breast tumor growth and metastasis. Nature 452: 187-193, 2008.
2. Parker B and Sukumar S: Distant metastasis in breast cancer: molecular mechanisms and therapeutic targets. Cancer Biol Ther 2: 14-21, 2003.
3. Hao ZH, Li X, Qiao T, Du R, Hong L and Fan D: CIAPIN1 congers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells. Cancer Biol Ther 5: 261-266, 2006.
4. Ozben T: Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett 580: 2903-2909, 2006.
5. Pienta KJ and Smith DC: Advances in prostate cancer chemotherapy: a new era begins. CA Cancer J Clin 55: 300-318, 2005.
6. Spector DL: The dynamics of chromosome organization and gene regulation. Annu Rev Biochem 72: 573-608, 2003.
7. Cai S, Han HJ and Kohwi-Shigematsu T: Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nature Genet 34: 42-51, 2003.
8. Yasui D, Miyano M, Cai S, Varga-Weisz P and Kohwi-Shigematsu T: SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419: 641-645, 2002.
9. Dickinson LA, Joh T, Kohwi Y and Kohwi-Shigematsu T: A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 70: 631-645, 1992.
10. Agrelo R, Souabni A, Novatchkova M, Haslinger C, Leeb M, Komnenovic V, Kishimoto H, Gresh L, Kohwi-Shigematsu T, Kenner L and Wutz A: SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell 16: 507-516, 2009.
11. Nakayama Y, Mian IS, Kohwi-Shigematsu T and Ogawa T: A nuclear targeting determinant for SATB1, a genome organizer in the T cell lineage. Cell Cycle 4: 1099-1106, 2005.
12. Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY and Kohwi-Shigematsu T: The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev 14: 521-535, 2000.
13. Zheng J: Is SATB1 a master regulator in breast cancer growth and metastasis? Womens Health (Lond Engl) 4: 329-332, 2008.
14. Li QQ, Chen ZQ, Xu JD, Cao XX, Chen Q, Liu XP and Xu ZD: Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells. Cancer Sci 101: 80-86, 2010.
15. Lu X, Cheng C, Zhu S, Yang Y, Zheng L, Wang G, Shu X, Wu K, Liu K and Tong Q: SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep 24: 981-987, 2010.
16. Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD and Wang LH: Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67: 1979-1987, 2007.
17. Li QQ, Wang WJ, Xu JD, Cao XX, Chen Q, Yang JM and Xu ZD: Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. Cancer Sci 98: 1064-1069, 2007.
18. Shi Y, Zhai H, Wang X, Han Z, Liu C, Lan M, Du J, Guo C, Zhang Y, Wu K and Fan D: Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis. Exp Cell Res 296: 337-346, 2004.
19. Maxwell SA and Davis GE: Biological and molecular characterization of an ECV-304-derived cell line resistant to p53-mediated apoptosis. Apoptosis 5: 277-290, 2000.
20. Wen J, Huang S, Rogers H, Dickinson LA, Kohwi-Shigematsu T and Noguchi CT: SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood 105: 3330-3339, 2005.
21. Zhao Y, You H, Liu F, An H, Shi Y, Yu Q and Fan D: Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 185: 211-218, 2002.
22. Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002.
23. Wang Y, Su M, Zhou LL, Tu P, Zhang X, Jiang X and Zhou Y: Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription. Blood 117: 3826-3835, 2011.
24. Gorlick R and Bertino JR: Drug resistance in colon cancer. Semin Oncol 26: 606-611, 1999.
25. Naito S, Yokomizo A and Koga H: Mechanisms of drug resistance in chemotherapy for urogenital carcinoma. Int J Urol 6: 427-439, 1999.
26. Dong X and Mumper RJ: Nanomedicinal strategies to treat multidrug-resistant tumors current progress. Nanomedicine (Lond) 5: 597-615, 2010.
27. Colone M, Calcabrini A, Toccacieli L, Bozzuto G, Stringaro A, Gentile M, Cianfriglia M, Ciervo A, Caraglia M, Budillon A, et al: The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? J Invest Dermatol 128: 951-971, 2008.